ROCKET PHARMACEUTICALS, INC. (RCKT)
Nasdaq: RCKT · CIK 0001281895 · United States
Every official ROCKET PHARMACEUTICALS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RCKT filings
ROCKET PHARMACEUTICALS, INC. documents
- ROCKET PHARMACEUTICALS, INC. 10-K 2026RCKT 10-K 2026: annual report for fiscal 2026
- ROCKET PHARMACEUTICALS, INC. 10-K 2025RCKT 10-K 2025: annual report for fiscal 2025
- ROCKET PHARMACEUTICALS, INC. 10-K 2024RCKT 10-K 2024: annual report for fiscal 2024
- ROCKET PHARMACEUTICALS, INC. 10-K 2023RCKT 10-K 2023: annual report for fiscal 2023
- ROCKET PHARMACEUTICALS, INC. 10-K 2022RCKT 10-K 2022: annual report for fiscal 2022
- ROCKET PHARMACEUTICALS, INC. 10-Q 2026RCKT 10-Q 2026: quarterly report for fiscal 2026
- ROCKET PHARMACEUTICALS, INC. 10-Q 2025RCKT 10-Q 2025: quarterly report for fiscal 2025
- ROCKET PHARMACEUTICALS, INC. 10-Q 2024RCKT 10-Q 2024: quarterly report for fiscal 2024
- ROCKET PHARMACEUTICALS, INC. 10-Q 2023RCKT 10-Q 2023: quarterly report for fiscal 2023
- ROCKET PHARMACEUTICALS, INC. 10-Q 2022RCKT 10-Q 2022: quarterly report for fiscal 2022
- ROCKET PHARMACEUTICALS, INC. 8-K 2026RCKT 8-K 2026: current report for fiscal 2026
- ROCKET PHARMACEUTICALS, INC. 8-K 2025RCKT 8-K 2025: current report for fiscal 2025
- ROCKET PHARMACEUTICALS, INC. 8-K 2024RCKT 8-K 2024: current report for fiscal 2024
- ROCKET PHARMACEUTICALS, INC. 8-K 2023RCKT 8-K 2023: current report for fiscal 2023
- ROCKET PHARMACEUTICALS, INC. 8-K 2022RCKT 8-K 2022: current report for fiscal 2022
- ROCKET PHARMACEUTICALS, INC. DEF 14A 2026RCKT DEF 14A 2026: proxy statement for fiscal 2026
- ROCKET PHARMACEUTICALS, INC. DEF 14A 2025RCKT DEF 14A 2025: proxy statement for fiscal 2025
- ROCKET PHARMACEUTICALS, INC. DEF 14A 2024RCKT DEF 14A 2024: proxy statement for fiscal 2024
- ROCKET PHARMACEUTICALS, INC. DEF 14A 2023RCKT DEF 14A 2023: proxy statement for fiscal 2023
- ROCKET PHARMACEUTICALS, INC. DEF 14A 2022RCKT DEF 14A 2022: proxy statement for fiscal 2022
- ROCKET PHARMACEUTICALS, INC. Form 4 2026RCKT Form 4 2026: insider trading filing for fiscal 2026
- ROCKET PHARMACEUTICALS, INC. Form 4 2025RCKT Form 4 2025: insider trading filing for fiscal 2025
- ROCKET PHARMACEUTICALS, INC. Form 4 2024RCKT Form 4 2024: insider trading filing for fiscal 2024
- ROCKET PHARMACEUTICALS, INC. Form 4 2023RCKT Form 4 2023: insider trading filing for fiscal 2023
- ROCKET PHARMACEUTICALS, INC. Form 4 2022RCKT Form 4 2022: insider trading filing for fiscal 2022
- ROCKET PHARMACEUTICALS, INC. S-1 2026RCKT S-1 2026: registration statement for fiscal 2026
- ROCKET PHARMACEUTICALS, INC. S-1 2025RCKT S-1 2025: registration statement for fiscal 2025
- ROCKET PHARMACEUTICALS, INC. S-1 2024RCKT S-1 2024: registration statement for fiscal 2024
- ROCKET PHARMACEUTICALS, INC. S-1 2023RCKT S-1 2023: registration statement for fiscal 2023
- ROCKET PHARMACEUTICALS, INC. S-1 2022RCKT S-1 2022: registration statement for fiscal 2022
- ROCKET PHARMACEUTICALS, INC. 13F 2026RCKT 13F 2026: institutional holdings for fiscal 2026
- ROCKET PHARMACEUTICALS, INC. 13F 2025RCKT 13F 2025: institutional holdings for fiscal 2025
- ROCKET PHARMACEUTICALS, INC. 13F 2024RCKT 13F 2024: institutional holdings for fiscal 2024
- ROCKET PHARMACEUTICALS, INC. 13F 2023RCKT 13F 2023: institutional holdings for fiscal 2023
- ROCKET PHARMACEUTICALS, INC. 13F 2022RCKT 13F 2022: institutional holdings for fiscal 2022
More companies